Congenitally Corrected Transposition of the Great Arteries: Clinical Trials

1 completed. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Completed 1

Follow Congenitally Corrected Transposition of the Great Arteries: new trials by email Literature Review of Congenitally Corrected Transposition of the Great Arteries trials Research Report on Congenitally Corrected Transposition of the Great Arteries

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function Tadalafil 20 MG, Placebo 20 MG - Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion	Phase 3	Completed	Insel Gruppe AG, University Hospital Bern	100	2017-10-25	2023-06-23

Narrower conditions

Heart Defects, Congenital (1)

Broader conditions

Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Heart Diseases (1)  ·  Transposition of Great Vessels (1)

Interventions

Tadalafil (1)

Sponsors

Insel Gruppe AG, University Hospital Bern (1)

Countries

Austria (1)  ·  Switzerland (1)

Top investigators

Markus Schwerzmann, MD (1)

Results publications

PMID 16765134, PMID 17210844, PMID 17606845, PMID 22192662, PMID 23067916, PMID 23247302, PMID 23790549, PMID 23972966, PMID 24589851, PMID 24644309, PMID 26185211, PMID 28566262, PMID 37264734, PMID 38726920, PMID 40470125